Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

The effects of chemotherapy on breast cancer tissue in locally advanced breast cancer.

Aktepe F, Kapucuoğlu N, Pak I.

Histopathology. 1996 Jul;29(1):63-7.

PMID:
8818696
2.

Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.

Gajdos C, Tartter PI, Estabrook A, Gistrak MA, Jaffer S, Bleiweiss IJ.

J Surg Oncol. 2002 May;80(1):4-11.

PMID:
11967899
3.

Identification and evaluation of axillary sentinel lymph nodes in patients with breast carcinoma treated with neoadjuvant chemotherapy.

Cohen LF, Breslin TM, Kuerer HM, Ross MI, Hunt KK, Sahin AA.

Am J Surg Pathol. 2000 Sep;24(9):1266-72.

PMID:
10976701
4.

The effects of hormonal and chemotherapy on tumoral and nonneoplastic breast tissue.

Kennedy S, Merino MJ, Swain SM, Lippman ME.

Hum Pathol. 1990 Feb;21(2):192-8.

PMID:
2155174
5.

The presence of proliferative breast disease with atypia does not significantly influence outcome in early-stage invasive breast cancer treated with conservative surgery and radiation.

Fowble B, Hanlon AL, Patchefsky A, Freedman G, Hoffman JP, Sigurdson ER, Goldstein LJ.

Int J Radiat Oncol Biol Phys. 1998 Aug 1;42(1):105-15.

PMID:
9747827
6.

Prognostic significance of pathological response of primary tumor and metastatic axillary lymph nodes after neoadjuvant chemotherapy for locally advanced breast carcinoma.

Machiavelli MR, Romero AO, Pérez JE, Lacava JA, Domínguez ME, Rodríguez R, Barbieri MR, Romero Acuña LA, Romero Acuña JM, Langhi MJ, Amato S, Ortiz EH, Vallejo CT, Leone BA.

Cancer J Sci Am. 1998 Mar-Apr;4(2):125-31.

PMID:
9554929
7.

[Locally advanced non inflammatory breast cancer treated by combined chemotherapy and preoperative irradiation: updated results in a series of 120 patients].

Lerouge D, Touboul E, Lefranc JP, Genestie C, Moureau-Zabotto L, Blondon J.

Cancer Radiother. 2004 Jun;8(3):155-67. French.

PMID:
15217583
8.

Changes in management techniques and patterns of disease recurrence over time in patients with breast carcinoma treated with breast-conserving therapy at a single institution.

Pass H, Vicini FA, Kestin LL, Goldstein NS, Decker D, Pettinga J, Ingold J, Benitez P, Neumann K, Rebner M, Dekhne N, Martinez A.

Cancer. 2004 Aug 15;101(4):713-20.

9.

Morphologic effects of neoadjuvant chemotherapy in locally advanced breast cancer.

Moll UM, Chumas J.

Pathol Res Pract. 1997;193(3):187-96.

PMID:
9198104
10.

T1-T2 breast cancer with four or more positive axillary lymph nodes: adjuvant locoregional radiotherapy with high-dose or standard-dose chemotherapy. Results of an observational study.

Perrucci E, Aristei C, De Angelis V, Anselmo P, Mascioni F, Gori S, Frattegiani A, Latini P.

Tumori. 2004 Jul-Aug;90(4):379-86.

PMID:
15510979
11.

Local recurrence in patients with large and locally advanced breast cancer treated with primary chemotherapy.

McIntosh SA, Ogston KN, Payne S, Miller ID, Sarkar TK, Hutcheon AW, Heys SD.

Am J Surg. 2003 Jun;185(6):525-31.

PMID:
12781879
12.

Radiation-induced changes in the breast.

Schnitt SJ, Connolly JL, Harris JR, Cohen RB.

Hum Pathol. 1984 Jun;15(6):545-50.

PMID:
6724573
13.

Pathobiology of preoperative chemotherapy: findings from the National Surgical Adjuvant Breast and Bowel (NSABP) protocol B-18.

Fisher ER, Wang J, Bryant J, Fisher B, Mamounas E, Wolmark N.

Cancer. 2002 Aug 15;95(4):681-95.

14.

Selection of local therapy after neoadjuvant chemotherapy in patients with stage IIIA,B breast cancer.

Danforth DN Jr, Zujewski J, O'Shaughnessy J, Riseberg D, Steinberg SM, McAtee N, Noone M, Chow C, Chaudhry U, Lippman M, Jacobson J, Okunieff P, Cowan KH.

Ann Surg Oncol. 1998 Mar;5(2):150-8.

PMID:
9527268
15.

Sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy.

Reitsamer R, Peintinger F, Rettenbacher L, Prokop E.

J Surg Oncol. 2003 Oct;84(2):63-7.

PMID:
14502778
16.

Should histologic type be taken into account when considering neoadjuvant chemotherapy in breast carcinoma?

Sullivan PS, Apple SK.

Breast J. 2009 Mar-Apr;15(2):146-54. doi: 10.1111/j.1524-4741.2009.00689.x.

PMID:
19292800
17.

The importance of the histologic grade of invasive breast carcinoma and response to chemotherapy.

Pinder SE, Murray S, Ellis IO, Trihia H, Elston CW, Gelber RD, Goldhirsch A, Lindtner J, Cortés-Funes H, Simoncini E, Byrne MJ, Golouh R, Rudenstam CM, Castiglione-Gertsch M, Gusterson BA.

Cancer. 1998 Oct 15;83(8):1529-39.

PMID:
9781946
18.
19.

Patients with early stage invasive cancer with close or positive margins treated with conservative surgery and radiation have an increased risk of breast recurrence that is delayed by adjuvant systemic therapy.

Freedman G, Fowble B, Hanlon A, Nicolaou N, Fein D, Hoffman J, Sigurdson E, Boraas M, Goldstein L.

Int J Radiat Oncol Biol Phys. 1999 Jul 15;44(5):1005-15.

PMID:
10421533
20.

Lymphatic mapping and sentinel lymphadenectomy in early stage breast carcinoma.

Altinyollar H, Kapucuoglu N, Pak I, Berberoglu U.

J Exp Clin Cancer Res. 2000 Jun;19(2):141-4.

PMID:
10965808

Supplemental Content

Support Center